FAKTOR OPTIONSSCHEIN - MEDTRONIC Stock

Certificat

DE000GP5M5E1

Market Closed - BOERSE MUENCHEN 14:26:16 2024-06-28 EDT
0.581 EUR +7.79% Intraday chart for FAKTOR OPTIONSSCHEIN - MEDTRONIC
Current month-27.65%
1 month-38.32%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-28 0.581 +7.79%
24-06-27 0.539 -13.76%
24-06-26 0.625 -0.79%
24-06-25 0.63 -13.58%
24-06-24 0.729 -0.55%

Real-time BOERSE MUENCHEN

Last update June 28, 2024 at 02:26 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer Goldman Sachs
WKN GP5M5E
ISINDE000GP5M5E1
Date issued 2023-06-09
Strike 70.77 $
Maturity Unlimited
Parity 13.17 : 1
Emission price 8.62
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 17.18
Lowest since issue 0.539
Spread 0.01
Spread %1.75%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
78.71 USD
Average target price
94.02 USD
Spread / Average Target
+19.46%
Consensus